Skip to Content

Great Elm Group reports DME loss 

Great Elm Group reports DME loss 

WALTHAM, Mass. – Great Elm Group reported DME revenue of $13.1 million for its third quarter 2021, compared to $14.1 million for the same quarter last year. 

It reported a net loss of $5.1 million vs. a net loss of $1.4 million, and adjusted EBITDA of $3.4 million, vs. $2.5 million. 

"Overall, we see positive momentum in all aspects of our business,” said Peter A. Reed, CEO. “DME is beginning to see signs of business recovery from the pandemic impacts, as the country continues moving toward a full economic reopening. We are optimistic about the resumption of organic growth at DME and also the potential for future acquisitions.” 

In March, the company announced it had acquired Advanced Medical DME and PM Sleep Lab, with locations in Kansas and Missouri through its Focus Respiratory subsidiary. 

“During the quarter, DME resumed its acquisition program and announced the AMPM acquisition, which strengthens DME’s presence in the Midwest and provides future organic growth potential through an expanded patient base and cross-selling opportunities,” Reed said. “We also anticipate the acquisition will drive margin improvement through operational efficiencies and other benefits of added scale.” 

 

Comments

To comment on this post, please log in to your account or set up an account now.